Skip to content

Valeant eyes sale of $2.5B new bonds

March 7, 2017

Valeant Pharma (NYSE: VRX) is in talks to sell $2.5 billion of secured bonds, according to Bloomberg, citing sources. Banks have discussed selling bonds in two parts, with five and seven-year maturities. Valeant could make the notes at yields of about 6.5% and 7%, respectively.

http://bit.ly/2naQ8DF

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: